Select Page

South Delhi Pharma, New Delhi, India

RYDAPT (midostaurin) capsules, for oral use

(4 customer reviews)

Under Named Patient Supply, SDP serve you through the quality pharmaceutical products as per your needs. Established in the year 1996. SDP have earned global reputation in the market and has widest range of Anti Cancer medicines in India. To get the best price/cost of medicines in India, Call 9891296838 or Email query@southdelhipharma.com to discuss.

Facts of Rydapt (Midostaurin Capsules)

Product: RYDAPT® (midostaurin) capsules, for oral use
Indication: blood cell cancer (acute myeloid leukemia-AML, mast cell leukemia-MCL)
Strength: Capsules: 25 mg
Company: Novartis Pharmaceuticals Corporation

South Delhi Pharma can facilitate patients and physicians access to commercially approved medicines, “Rydapt (Midostaurin ) ” to all locations in the world and in India after fulfilling the legal requirement (if applicable). Rydapt (Midostaurin) is a prescription drug and should be used under proper medical guidance and advice. The order will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Category:

Get In Touch

Get in touch with us at South Delhi Pharma (SDP), and one of our team will be on hand to help with any queries you may have.

The SDM is open
Monday to Friday.
Business hours: 09:30 A.M to 18:30 P.M.

Contact Number:
M:+91-9891296838 / P:+91-11- 26532129

Email ID:
info@southdelhipharma.com

What Rydapt is?

RYDAPT is a kinase inhibitor indicated for the treatment of adult patients with:
• Newly diagnosed acute myeloid leukemia (AML) that is FLT3 mutationpositive as detected by an FDA-approved test, in combination with standard cytarabine and daunorubicin induction and cytarabine consolidation.
Limitations of Use:
RYDAPT is not indicated as a single-agent induction therapy for the treatment of patients with AML.
• Aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated hematological neoplasm (SM-AHN), or mast cell leukemia (MCL).

What Midostaurin is?

Midostaurin, sold under the brand name Rydapt, is a multi-targeted protein kinase inhibitor that has been investigated for the treatment of acute myeloid leukemia (AML), myelodysplastic syndrome (MDS) and advanced systemic mastocytosis. It is a semi-synthetic derivative of staurosporine, an alkaloid from the bacterium Streptomyces staurosporeus.

4 reviews for RYDAPT (midostaurin) capsules, for oral use

  1. alamece

    private kamagra Inform yourself about take- back programs in your town by speaking with your pharmacist or contacting your local trash or recycling agency

  2. Shickew

    kamagra online Full Text of Announcement

  3. Priopay

    taking doxycycline with food Science 293 1107 1112, 2001

  4. Elaluelry

    How to use Trial Antacid Tablet, Chewable discount cialis Don t overcrowd the cage with toys

Add a review

Your email address will not be published. Required fields are marked *